Kyntra Bio, Inc. (KYNB)
8.78
-0.19
(-2.12%)
USD |
NASDAQ |
Jan 23, 13:33
Kyntra Bio Research and Development Expense (TTM): 23.12M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Assertio Holdings, Inc. | 2.49M |
| Perspective Therapeutics, Inc. | 61.22M |
| Skye Bioscience, Inc. | 38.14M |
| Theravance Biopharma, Inc. | 37.97M |
| Myomo, Inc. | 6.879M |